Qiagen Manager Pledges Shares in Securities Lending Transaction

Qiagen ( (QGEN) ) has issued an announcement.

Qiagen N.V. announced a manager’s transaction involving Thierry Bernard, a member of the managing body, who pledged 114,285 shares of the company as part of a securities lending transaction. This transaction, conducted outside a trading venue, reflects internal financial maneuvers that could influence the company’s stock dynamics and stakeholder perceptions.

More about Qiagen

Qiagen N.V. operates in the biotechnology industry, specializing in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is known for its products that enable the isolation, purification, and analysis of DNA, RNA, and proteins, serving a global market with a focus on improving healthcare outcomes.

YTD Price Performance: -10.56%

Average Trading Volume: 1,178,199

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: $8.59B

Find detailed analytics on QGEN stock on TipRanks’ Stock Analysis page.